Mangaluru: A feasibility study by the Karnataka Digital Economy Mission (KDEM) to assess whether the city can be designated ...
Takeda tightened its pipeline in the third quarter. Innovent Biologics reported a head-to-head win against semaglutide in a Chinese phase 3 trial. | Takeda tightened its pipeline in the third quarter.
StockStory.org on MSN
Why Moderna (MRNA) Stock Is Trading Lower Today
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.5% in the afternoon session after the stock ...
Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.
Get all latest business news and top breaking latest news in India about elections, coronavirus lockdown and curfew, union budget, sports, technology, share market, healthcare, IPOs, mutual fund, ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback